• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROMODULATION INTERSTIM; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCON

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROMODULATION INTERSTIM; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCON Back to Search Results
Model Number NEU_INTERSTIM_INS
Device Problem Migration or Expulsion of Device (1395)
Patient Problems Purulent Discharge (1812); Unspecified Infection (1930)
Event Type  Injury  
Manufacturer Narrative
Continuation of d10: product id neu_unknown_lead lot# unknown.Product type lead section d information references the main component of the system.Other relevant device(s) are: product id: neu_unknown_lead.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
Information was received from multiple sources (manufacturer representative, healthcare provider) regarding a patient who was implan ted with an implantable neurostimulator (ins) for unknown indications for use.It was reported that patient had two basic evaluation leads in place but never contacted field rep or provided a support link to complain of complications, patient never responded to at tempt by field rep prior to lead pull, and patient missed original lead pull appointment.Complications were communicated by the md's nurse practitioner to the field rep on the day of the rescheduled lead pull. email from nurse practitioner during dressing removal , odorous purulent drainage expressed from the basic evaluation lead site, cultures taken, 4x6cm area of firmness noted, pt placed on antibiotic, and follow-up scheduled. pt has a follow-up on friday, (b)(6) 2024.
 
Event Description
Additional information was received from a manufacturer representative (rep).The rep reported that the patient was seen again today.Their ct showed an ill-defined collection but no well marinated abscess.Cx positive for staph-treated with clina.Approximately 50% better today.The hcp wants a ct repeated and to add bactrim to coverage.Rep noted they will update as this occurs.
 
Manufacturer Narrative
Product id neu_unknown_lead lot# unknown serial# implanted: explanted: product type lead medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
Additional information was received from a manufacturer representative (rep).The rep reported that the previously noted inflammation involving the left buttock musculature was much improved with only minor superficial edema at the site.There was no definable fluid collection or abscess.Continued clinical follow-up was advised.The area was free of erythema, nontender, no longer open, and had no drainage.The patient was asking how soon they could proceed with the implant.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTERSTIM
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCON
Manufacturer (Section D)
MEDTRONIC NEUROMODULATION
7000 central ave ne
minneapolis MN 55432
Manufacturer (Section G)
MEDTRONIC NEUROMODULATION
7000 central ave ne
minneapolis MN 55432
Manufacturer Contact
glen belmer
7000 central avenue ne rcw215
minneapolis, MN 55432
6122713209
MDR Report Key19154960
MDR Text Key340742201
Report Number2182207-2024-02364
Device Sequence Number1
Product Code EZW
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P970004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/10/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberNEU_INTERSTIM_INS
Device Catalogue NumberNEU_INTERSTIM_INS
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/17/2024
Initial Date FDA Received04/22/2024
Supplement Dates Manufacturer Received04/23/2024
Supplement Dates FDA Received05/10/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
"SEE H11...."
Patient Outcome(s) Required Intervention;
-
-